Prevalence and Antimicrobial Susceptibility of Bacterial Uropathogens Isolated from Pediatric Patients at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia

Table 5

The number and percent of resistant strains of Gram-positive uropathogens among pediatric patients at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia, 2014.

Bacteria isolated	Total no.	Antimicrobial agents tested
		P	CIP	C	E	OX	CXM	GN	KF	SXT	F	DA	AMP	CRO
		No. (%)	No. (%)	No. (%)	No. (%)	No. (%)	No. (%)	No. (%)	No. (%)	No. (%)	No. (%)	No. (%)	No. (%)	No. (%)
Enterococcus spp.	7	0	1 (14.3)	5 (71.4)	6 (85.7)	—	3 (42.9)	0	3 (42.9)	6 (85.7)	1 (14.3)	0	3 (42.9)	3 (42.9)
CONS	4	0	1 (25.0)	1 (25.0)	4 (100)	—	4 (100)	0	0	4 (100)	0	0	1 (25.0)	1 (25.0)
S. aureus	1	1 (100)	0	0	1 (100)	0	0	0	1 (100)	0	0	0	1 (100)	0
Total	12	1 (8.3)	2 (16.6)	6 (50)	11 (91.6)	0	7 (58.3)	0	4 (33.3)	10 (83.3)	1 (8.3)	0	5 (41.6)	4 (33.3)

CONS: coagulase-negative staphylococci; P: penicillin (10 U); AMP: augmentin (30 μg); KF: cephalothin (10 μg); DA: clindamycin (30 μg); CRO: ceftriaxone (10 μg); GN: gentamicin (30 μg); E: erythromycin (15 μg); CIP: ciprofloxacin (5 μg); OX: oxacillin (1 μg); F: nitrofurantoin (30 μg); C: chloramphenicol (30 μg); SXT: trimethoprim-sulfamethoxazole (1.25/23.75 μg); CXM: cefuroxime (30 μg).